Back to search
FDAFDA · Food and drugs·Recall number D-826-2013

Belladonna Alkaloids/PB (Belladonna Alkaloids / Phenobarbital) Tablets Phenobarbital USP 16.2 mg, Hyoscyamine Sulfate 0.1037 mg, Atropine Sulfate 0.0194 mg, Scopolamine Hydrobromide 0.0065 mg 30-count bottle (NDC 54868-0031-04), Rx only, Repackaged and distributed by Physicians Total Care, Inc. Tulsa, OK 74146.

Published August 7, 2013 · Recall initiated: June 17, 2013

Summary

FDA records drug Class II recall D-826-2013, published August 7, 2013 and initiated June 17, 2013. Recalling firm: Physicians Total Care, Inc.; Status: Terminated; Reported quantity: 270 tablets; Lot: Lot# 6GP2; Exp 10/14 West-Ward Lot /WWCN 67331A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager initiated its own recall.

What to do

Voluntary: Firm initiated · FAX

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Physicians Total Care, Inc.
Distributor
GA
Lot
Lot# 6GP2; Exp 10/14 West-Ward Lot /WWCN 67331A
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Belladonna Alkaloids/PB (Belladonna Alkaloids / Phenobarbital) Tablets Phenobarbital USP 16.2 mg, Hyoscyamine Sulfate 0.1037 mg, Atropine Sulfate 0.0194 mg, Scopolamine Hydrobromide 0.0065 mg 30-count bottle (NDC 54868-0031-04), Rx only, Repackaged and distributed by Physicians Total Care, Inc. Tulsa, OK 74146. recalled?

Yes. FDA published recall D-826-2013 on August 7, 2013. Reported hazard: Presence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager initiated its own recall.

What should I do if I have this product?

Voluntary: Firm initiated · FAX